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Abstract
In vitro studies have shown several beneﬁcial properties of resveratrol. Epidemiological evidence is still scarce, probably because of the
difﬁculty in estimating resveratrol exposure accurately. The current study aimed to assess the relationships between acute and habitual dietary
resveratrol and wine intake and urinary resveratrol excretion in a European population. A stratiﬁed random subsample of 475 men and
women from four countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) cross-sectional study,
who had provided 24-h urine samples and completed a 24-h dietary recall (24-HDR) on the same day, were included. Acute and habitual
dietary data were collected using standardised 24-HDR software and a validated country-speciﬁc dietary questionnaire, respectively. Phenol-
Explorer was used to estimate the intake of resveratrol and other stilbenes. Urinary resveratrol was analysed using tandem MS. Spearman’s
correlation coefﬁcients between estimated dietary intakes of resveratrol and other stilbenes and consumption of wine, their main food source,
were very high (r> 0·9) when measured using dietary questionnaires and were slightly lower with 24-HDR (r> 0·8). Partial Spearman’s
Abbreviations: 24-HDR, 24-h dietary recall; DQ, dietary questionnaire.
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correlations between urinary resveratrol excretion and intake of resveratrol, total stilbenes or wine were found to be higher when using the
24-HDR (R2partial approximately 0·6) than when using the dietary questionnaires (R
2
partial approximately 0·5). Moderate to high correlations
between dietary resveratrol, total stilbenes and wine, and urinary resveratrol concentrations were observed. These support the earlier ﬁndings
that 24-h urinary resveratrol is an effective biomarker of both resveratrol and wine intakes. These correlations also support the validity of the
estimation of resveratrol intake using the dietary questionnaire and Phenol-Explorer.
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Resveratrol (3,5,4'-trihydroxystilbene) is the most well-known
stilbene. This polyphenol class also includes piceid (resveratrol
glucoside), pallidol and viniferins (resveratrol oligomers), and
piceatannol (tetrahydroxystilbene). In the last two decades,
resveratrol and other stilbenes have received considerable
attention, particularly in in vitro and preclinical studies, because
of their various biological properties such as antioxidant and
anti-inﬂammatory effects(1,2). Their capacity to modulate several
signalling pathways leads to important cellular processes such
as apoptosis, inhibition of angiogenesis and tumour growth
as well as lipidic and glycaemic modulation(1,2). However,
evidence from epidemiological studies regarding effects
on health is lacking, because of the difﬁculty in accurately
estimating resveratrol exposure in large population-based
samples, and because of the low levels of resveratrol
observed in humans in non-experimental conditions compared
with those in experimental conditions(2,3).
Resveratrol and its derivatives are found in at least seventy-two
plant species, including twelve families and thirty-one genera,
but they are found in only a limited number of edible foods
(online Supplementary Table S1)(4,5). The primary sources of
stilbenes are grapes and wine, especially red wine(4,5). They can
also be found in minor concentrations in peanuts, pistachios,
berries(4,5), dark chocolate(6), some beers(7) and in some varieties
of tomatoes(8) and apples(9). Dietary intake of stilbenes in Europe
is between 2 and 3mg/d, and resveratrol and piceid represent
about 50% of the total stilbene intake(10).
Resveratrol and piceid, after hydrolysis, are absorbed in the
small intestine and extensively metabolised into glucuronides
and sulphates. Unabsorbed resveratrol reaches the colon and is
converted into dihydroresveratrol by the microbiota, which can
also be absorbed, accounting for as much as 50% of an oral
resveratrol dose(11). Experiments with radiolabelled resveratrol
have shown a high absorption of resveratrol in the gut, with
more than 70% of the ingested radioactivity recovered in
urine(11). To date, very little information is available on the
bioavailability of other stilbenes such as piceatannol(12) and
viniferins(13); although, to the best of our knowledge, they are
not parent compounds of urinary resveratrol(14).
Few studies assessing the ability of urinary resveratrol to
serve as a biomarker of wine and resveratrol intake have been
published. These studies have been conducted in Mediterranean
countries where wine intake is high(15). One interventional(16) and
two observational studies(17,18) showed high correlations between
habitual intake of wine or resveratrol and piceid and the
concentration of resveratrol metabolites in spot urine samples.
High correlations were also observed between dihydroresveratrol
glucuronide and resveratrol concentrations measured in 24-h urine
samples and acute intake of wine on the day of urine collection in
a cross-sectional study in four European countries(19,20).
In the present study, we aimed to investigate the correlation
between acute and habitual dietary intakes of resveratrol and
stilbenes, and their main food sources, and concentrations of
urinary resveratrol in 24-h urine. First, our study assessed the
usefulness of urinary resveratrol as a biomarker of resveratrol and
wine consumption. Second, it evaluated the validity of using
a dietary questionnaire (DQ) and the Phenol-Explorer food
composition database(5) to estimate the dietary resveratrol intake.
Methods
Study population
The European Prospective Investigation into Cancer and
Nutrition (EPIC) study is a cohort study with over half a million
participants of both sexes mostly recruited from the general
population between 1992 and 2000 in twenty-three centres
in ten European countries(21). In a convenience subsample
of 475 men and women, aged 50–61 years, a single 24-h dietary
recall (24-HDR) and 24-h urine samples were collected on the
same day between the years 1995 and 1999(20). Approval for
the study was obtained from the ethical review boards of the
International Agency for Research on Cancer and from all
participating institutions. All participants also provided written
informed consent.
Dietary and lifestyle information
Short-term dietary data were collected using a single 24-HDR
harmonised across countries (EPIC-Soft)(22). The 24-HDR was
administered in a face-to-face interview. Habitual dietary data
were assessed at recruitment using a centre-speciﬁc quantitative
DQ (France, Germany, Greece and Italy, except Naples) or a
semi-quantitative FFQ (Naples) developed and validated in
each country/centre(21,23). The mean time interval between the
DQ and the 24-HDR interview varied by country, from 1d to
3 years later(24). Dietary resveratrol and resveratrol 3-O-glucoside
(piceid) intakes were estimated using Phenol-Explorer(5), a
comprehensive food composition database on polyphenols,
as described in detail elsewhere(10). Resveratrol aglycone
equivalents were calculated as the sum of resveratrol and piceid
contents after conversion of piceid to resveratrol equivalents
on the basis of molecular weight. Total energy intake was
estimated using the standardised EPIC Nutrient Database(25).
Data on education, physical activity and smoking history
were collected at baseline using questionnaires(24,26). Data
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on age, body weight and height were self-reported by study
participants during the 24-HDR interview.
Samples and analytical method
Urine samples over a 24-h period were collected and stored
at −20°C using boric acid as a preservative. Completeness
of the collection of 24-h urine samples was monitored using
p-aminobenzoic acid (PABA). Samples with PABA recovery <70
and >110% were excluded from this study(27).
Resveratrol was analysed in 24-h urine samples using ultra-
performance liquid chromatography–tandem MS(28). In brief,
urine samples were treated with a β-glucuronidase/sulfatase
enzyme mixture and extracted twice with ethyl acetate; all
phenolic groups in resveratrol were quantitatively dansylated
using a differential isotope-labelling method and quantiﬁed
using tandem MS. The limit of quantiﬁcation (LOQ) for resveratrol
was 0·02μM. Inter-assay and intra-assay CV were <10%. Urinary
excretion of resveratrol was expressed as μmol/24-h. A small
proportion of urinary excretion measurements (n 46) did not
meet predetermined analytical quality control criteria and were
therefore excluded from statistical analysis.
Statistical analyses
Urinary resveratrol concentrations that fell below the LOQ were
set to values corresponding to half the LOQ. Descriptive statistics
(medians and 10th and 90th percentiles) including consumers and
non-consumers were used for both urinary excretions and dietary
intakes. Kruskal–Wallis tests were used to compare urinary
resveratrol levels between groups of subjects with different
baseline demographics and lifestyle characteristics. Spearman’s
rank correlations were used to assess the association between
urinary resveratrol levels and dietary variables (stilbenes and
stilbene-rich foods) estimated using DQ and 24-HDR. Partial
Spearman’s correlations (R2partial) were computed to assess the
contribution of dietary resveratrol intake (using DQ or 24-HDR)
to urinary resveratrol levels while adjusting for other possible
confounders: sex, BMI, age at recruitment, smoking status (never
smoker, former smoker, current smoker) and total energy intake
(measured in the DQ or in the 24-HDR, as appropriate). All
statistical tests were two sided and the signiﬁcance level was
P< 0·05. All analyses were conducted using the Statistical Analysis
Software, release 9.3 (SAS Institute Inc.).
Results
Of the 429 subjects with urinary resveratrol data, ﬁfty-two
participants had urinary resveratrol concentrations <LOQ.
The median urinary excretions by centre, sex, age, BMI,
smoking status and total energy intake are shown in Table 1.
Excretion was higher in male subjects, in those aged 50–60
years and in those who were overweight (BMI 25–<30 kg/m2)
or had greater energy intake. The highest total urinary
resveratrol concentrations were observed in Italy and France
(0·09–0·19 μmol/24 h), whereas the lowest concentrations
were observed in Greece (0·04 μmol/24 h). A similar pattern of
habitual wine consumption by country was observed; the
median intake ranged from 13ml/d in Greece to 125ml/d in
Italian centres (data not tabulated).
Medians and 10th and 90th percentiles of the intake of
resveratrol and resveratrol 3-O-glucoside and their food sources
(e.g. wine, grapes, peanuts and red wine) are described in
Table 2. Medians of the sum of resveratrol and piceid intake
obtained using the 24-HDR were lower (0·10mg/d) than those
obtained using the DQ (0·42mg/d). As expected, a higher
number of subjects with negligible intake of the sum of
resveratrol and piceid was found using the 24-HDR (n 82) than
using the DQ (n 0). Similar results were observed for wine, with
medians varying between 0 g/d (276 non-wine consumers) and
45 g/d (seventy non-wine consumers) in the 24-HDR and in the
DQ, respectively.
Spearman’s correlation coefﬁcients between urinary excre-
tion and intakes of different dietary stilbenes were >0·61 and
>0·55 as reported using 24-HDR and DQ (Table 3), respec-
tively. The correlation between the sum of resveratrol and
piceid intake and wine consumption was found to be 0·83 using
24-HDR and 0·95 using DQ. DQ data on red wine were
collected only in Italy (except in Naples); therefore, data were
available for 155 participants only. Correlations between red
wine consumption and the sum of resveratrol and piceid intake
were found to be lower in the 24-HDR (r 0·71) than in the DQ
(r 0·96). No signiﬁcant correlations were found with either
Table 1. Urinary resveratrol excretion (μmol/24 h) according to socio-
demographic and lifestyle factors in the European Prospective Investi-
gation into Cancer and Nutrition study
(Medians and 10th and 90th percentiles (P10 and P90))
Characteristics n Median P10 P90 P
Centre <0·001
Paris (FRA) 67 0·14 0·03 0·48
Florence (ITA) 45 0·17 0·03 0·84
Varese (ITA) 51 0·15 0·03 0·95
Ragusa (ITA) 17 0·19 0·04 1·21
Turin (ITA) 42 0·15 0·02 0·69
Naples (ITA) 20 0·09 0·03 0·84
Greece 56 0·04 0·02 0·10
Heidelberg (GER) 59 0·09 0·04 0·24
Potsdam (GER) 118 0·08 0·03 0·54
Sex 0·010
Men 198 0·10 0·03 0·75
Women 277 0··09 0·02 0·41
Age (years) 0·061
<50 151 0·09 0·02 0·51
50–60 201 0·11 0·03 0·60
>60 123 0·08 0·02 0·48
BMI (kg/m2) 0·043
<25 207 0·09 0·02 0·65
25–<30 186 0·10 0·03 0·53
≥30 82 0·08 0·02 0·34
Smoking status 0·111
Never smoker 241 0·09 0·02 0·48
Former smoker 129 0·10 0·03 0·71
Current smoker 92 0·07 0·02 0·42
Unknown 13 0·17 0·05 0·67
Total energy intake (kJ/d) 0·003
<7448 141 0·08 0·03 0·19
7448–9937 140 0·08 0·05 0·20
>9937 148 0·11 0·06 0·31
FRA, France; ITA, Italy; GER, Germany.
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grape or peanuts. DQ data on peanut intake were collected
only in Germany (n 177). The consumption of peanuts
was negligible (0 g/d in the percentile 90 using both DQ and
24-HDR), and the number of peanut consumers was only
fourteen of 475 subjects using the 24-HDR and thirty-three of
177 individuals using the DQ (Table 2).
The results of the multivariate-adjusted partial Spearman’s
correlations (R2partial) between the intake of resveratrol and
piceid, and their main food sources, and urinary resveratrol are
shown in Table 4. R2partial coefﬁcients were similar (R
2
partial
approximately 0·6) with resveratrol, piceid and wine using the
24-HDR. R2partial coefﬁcients were slightly lower (R
2
partial
approximately 0·5) using data from the DQ. For red wine, the
R2partial coefﬁcients were 0·55 and 0·50 for 24-HDR and DQ,
respectively.
Discussion
In the current study, resveratrol concentrations in 24-h urine were
correlated with acute (R2partial approximately 0·6) and habitual
(R2partial approximately 0·5) dietary resveratrol, piceid and wine
intake in a multicentre cohort of European adults. Habitual intake
of the sum of resveratrol and piceid has previously been reported
to correlate with concentrations of resveratrol metabolites (r 0·67),
glucuronides and sulphates analysed in 24-h urine samples in a
subsample of 783 men and women, aged 65 years and older, in
the Italian InCHIANTI (Invecchiare in Chianti) study(18). Higher
correlations (r 0·89) were observed between concentrations of
resveratrol metabolites in morning urine samples and the habitual
intake of resveratrol and piceid in a subsample of 1000 high-
cardiovascular-risk men and women in the Spanish PREDIMED
(Prevención con Dieta Mediterránea) study(17). The high correla-
tion in the Spanish study could be due to the large proportion of
red wine consumers (77%), whereas in our study the percentage
of red wine consumers was much lower (37%). In agreement with
this hypothesis, we observed higher Spearman’s correlations in
countries with high wine consumption, such as Italy (r 0·62, 38%
non-wine consumers), than in Germany (r 0·38, 78% non-wine
consumers). Therefore, urinary resveratrol concentration is a more
Table 3. Spearman’s correlations between urinary resveratrol (RESV) concentrations and acute intakes of RESV, RESV 3-O-
glucoside and their main food sources estimated with a single 24-h dietary recall and a dietary questionnaire in the European
Prospective Investigation into Cancer and Nutrition study
Urinary
RESV RESV
RESV
3-O-glucoside
RESV+RESV
3-O-glucoside
RESV
aglycone Wine Grape Red wine
24-h dietary recall
Urinary RESV 0·61 0·63 0·64 0·63 0·61 0·09 0·59
RESV 0·84 0·98 0·98 0·77 0·08 0·69
RESV 3-O-glucoside 0·92 0·90 0·85 0·07 0·73
RESV+RESV 3-O-glucoside 0·99 0·83 0·07 0·71
RESV aglycone 0·92 0·07 0·71
Wine −0·03 0·71
Grapes −0·04
Red wine
Dietary questionnaire
Urinary RESV 0·57 0·55 0·57 0·58 0·56 −0·01 0·61
RESV 0·92 0·97 0·98 0·90 0·08 0·95
RESV 3-O-glucoside 0·98 0·97 0·96 0·07 0·95
RESV+RESV 3-O-glucoside 0·99 0·95 0·07 0·96
RESV aglycone 0·94 0·07 0·96
Wine −0·03 0·91
Grapes −0·03
Red wine*
* Red wine data only collected using the dietary questionnaire in Italy, except Naples (n 155).
Table 2. Dietary intakes of resveratrol and piceid, their food sources and
urinary excretion of resveratrol in the European Prospective Investigation
into Cancer and Nutrition study (n 475)
(Medians and 10th and 90th percentiles (P10 and P90))
Variables
LOQ or non-
consumers (n) Median P10 P90
Urine 24h
Urinary resveratrol
(μmol/24 h)
52 0·09 0·02 0·54
24-h dietary recall
Resveratrol (mg/d) 84 0·04 0·00 0·81
Resveratrol 3-O-glucoside
(mg/d)
163 0·02 0·00 1·66
Resveratrol + resveratrol
3-O-glucoside (mg/d)
82 0·10 0·00 2·45
Resveratrol aglycone (mg/d) 82 0·07 0 1·74
Wine (g/d) 276 0·0 0·0 350·0
Grapes (g/d) 458 0·0 0·0 0·0
Peanuts (g/d) 461 0·0 0·0 0·0
Red wine (g/d) 354 0·0 0·0 260·0
DQ
Resveratrol (mg/d) 0 0·17 0·03 0·70
Resveratrol 3-O-glucoside
(mg/d)
0 0·24 0·02 1·57
Resveratrol + resveratrol
3-O-glucoside (mg/d)
0 0·42 0·06 2·27
Resveratrol aglycone (mg/d) 0 0·33 0·05 1·61
Wine (g/d) 70 44·5 0·0 283·5
Grapes (g/d) 31 7·1 0·3 33·2
Peanuts (g/d)* 144 0·0 0·0 0·03
Red wine (g/d)† 27 0·0 62·5 333·3
LOQ, limit of quantification; DQ, dietary questionnaire.
* Peanut data only collected using the DQ in Germany (n 177).
† Red wine data only collected using the DQ in Italy, except Naples (n 155).
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suitable biomarker of resveratrol exposure in populations with
elevated and regular intakes of resveratrol/wine than in those with
low and occasional intakes.
Approximately 70% of dietary resveratrol and piceid consumed
is recovered in urine as conjugates of resveratrol and dihydro-
resveratrol produced by the microbiota, which account for as much
as 50% of an oral resveratrol dose(11). Because of extensive
metabolism in the gut and the liver, most of the resveratrol found in
urine is glucuronidated and/or sulphated(29), and only 1% of
resveratrol absorbed is found in its free form in urine(11). Therefore,
in the analysis of urinary resveratrol, it is common practice to
measure it after enzymatic hydrolysis to release resveratrol agly-
cone, as done here(28). The current analytical method allowed us to
accurately quantify urinary resveratrol using a proper standard,
whereas, to date, standards for all conjugated metabolites of
resveratrol are not commercially available. In addition, this method
simultaneously analyses thirty-four urinary polyphenol aglycones,
allowing us to potentially measure several nutritional biomarkers of
polyphenol-rich foods at the same time(20).
Assessment of resveratrol intake in populations represents a
challenge for researchers primarily because of the variability and
paucity of data on resveratrol content of some foods, although
wine, particularly red wine, has been shown to be the main food
source (>92%) for total resveratrol and piceid intakes(4,10).
Resveratrol has been identiﬁed only in very few foods, mainly
grapes, grape juice and wine. Chocolate, pistachios, peanuts and
some varieties of berries(4,5), beer(7), tomatoes(8) and apples(9) also
contain resveratrol, but in very small concentrations, or they are
rarely consumed (i.e. berries) (online Supplementary Table S1).
Moreover, resveratrol content can vary greatly in the same type of
fruit, depending on variety, degree of maturity at harvest, fungal
pressure and climate(4,5). Indeed, resveratrol content in red wines
may vary up to 10-fold mainly owing to grape variety, Pinot noir
being the variety with the highest content(30). The development
of Phenol-Explorer in 2009 has facilitated the assessment of
resveratrol intake in epidemiological studies(5). However, to our
knowledge, this is the ﬁrst study correlating the estimation of
dietary resveratrol intake using Phenol-Explorer with urinary
resveratrol concentrations.
In the current study, similar correlations were observed
between urinary resveratrol concentrations and dietary intake
of either the sum of or individual resveratrol and piceid, or of
resveratrol and piceid expressed as resveratrol aglycone
equivalents. Therefore, urinary resveratrol excretion is a good
predictor of dietary resveratrol and piceid. This is because wine,
particularly red wine, is the main food source of resveratrol and
piceid (>92%)(4,10). Likewise, in our study, urinary resveratrol
level was also signiﬁcantly correlated with wine consumption,
especially with red wine intake, as previously described in other
studies(16,17). Other non-resveratrol-related metabolites such as
gallic acid ethyl ester, gallic acid ethyl ester sulphate, methyl-
gallic acid sulphate, 4-O-methylgallic acid and hydroxytyrosol
sulphate were also suggested as adequate biomarkers of red
wine(19,22). Combinations of several metabolites could be better
biomarkers of wine intake than individual compounds(31).
Urinary excretion mainly takes place in the ﬁrst 4h after
consumption (77% of total excretion), although resveratrol meta-
bolites remain in urine for at least 24h after intake(29,32). Therefore,
correlations between urinary and dietary resveratrol were found to
be higher when using 24-HDR (R2partial approximately 0·6),
a dietary assessment tool for short-term and acute dietary intake,
than when using DQ (R2partial approximately 0·5), a tool for
long-term and habitual dietary intake. Similar ﬁndings with other
polyphenols comparing short- with long-term dietary exposures
have been reviewed previously(33). Despite this, partial correlations
using DQ were still signiﬁcant. This is due to the fact that wine was
consumed on a regular basis by European adults in the 1990s,
especially in wine-producing countries such as France, Italy and
Spain. For example, the number of red wine consumers was 121
of 475 and 128 of 155 subjects (data collected only in some Italian
centres) on using the 24-HDR and DQ, respectively. Moreover,
using urinary resveratrol metabolites as biomarkers of wine con-
sumption, Zamora-Ros et al. were able to differentiate non-wine
consumers from sporadic consumers (one to three glasses of
wine per week) who had consumed their last glasses 3–5d before
urine collection(17). Overall, urinary resveratrol concentrations are
adequate biomarkers of short-term and habitual dietary resveratrol
intake in countries where wine is regularly consumed.
Our results may be inﬂuenced by measurement errors in the
24-HDR and DQ, which may attenuate our ﬁndings. However, the
24-HDR was collected using standardised software (EPIC-Soft) and
administered in a face-to-face interview(22). Furthermore, DQ were
country-speciﬁc and previously validated for some resveratrol-rich
foods such as wine(23). Second, estimation of dietary resveratrol
Table 4. R2partial coefficients between dietary resveratrol and resveratrol 3-O-glucoside intake and urinary resveratrol concentra-
tions in the European Prospective Investigation into Cancer and Nutrition study (n 429)*
Questionnaires Dietary variable Urinary resveratrol (μmol/24 h)
24-h dietary recall Resveratrol (mg/d) 0·57
Resveratrol 3-O-glucoside (mg/d) 0·59
Resveratrol + resveratrol 3-O-glucoside (mg/d) 0·59
Resveratrol aglycone (mg/d) 0·59
Wine (g/d) 0·59
Red wine (g/d) 0·55
Dietary questionnaire Resveratrol (mg/d) 0·51
Resveratrol 3-O-glucoside (mg/d) 0·49
Resveratrol + resveratrol 3-O-glucoside (mg/d) 0·51
Resveratrol aglycone (mg/d) 0·51
Wine (g/d) 0·51
Red wine (g/d) 0·50
* Spearman’s correlation model adjusted for centre, sex, age, BMI, smoking status and total energy intake.
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intake may be limited by the incompleteness of Phenol-Explorer,
although it is currently the most comprehensive database on
polyphenols including stilbenes(5). Finally, the results might also be
inﬂuenced by laboratory measurement error, although our analy-
tical methodology has fulﬁlled all criteria to be validated(28).
In conclusion, urinary excretion of resveratrol was
signiﬁcantly and positively associated with resveratrol, stilbene
and wine intakes estimated by 24-HDR and DQ. The correlation
coefﬁcients demonstrate that urinary resveratrol is an adequate
biomarker of both acute and habitual resveratrol and wine
intake in this population. Moreover, our results support
the validity of our methodology, 24-HDR, DQ and the food
composition database for estimating resveratrol intake. The
ﬁndings of this study lay the groundwork for future studies to
identify the role of resveratrol in the risk for chronic diseases.
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